Barry Downes on leading Affidea’s global growth - affidea growth strategy
Downes started as an engineer at Roadstone, a leading Irish construction materials firm, before transitioning to Cemex, where he became the company’s youngest plant manager.

Barry Downes, CEO of Affidea UK and Ireland, has spent seven years reshaping the company into a top independent healthcare provider. Since taking the helm, Affidea has grown to operate 24 clinical sites across the Republic of Ireland—covering minor injury units—and four centers in Northern Ireland. The company is pursuing an ambitious but disciplined expansion strategy to double the size of its UK & Ireland business over the next 24 months. This includes targeted acquisitions, greenfield development of new facilities, and the launch of additional clinical services.

His professional journey began in an unexpected field. Downes started as an engineer at Roadstone, a leading Irish construction materials firm, before transitioning to Cemex, where he became the company’s youngest plant manager. He later took on senior roles in operations and business turnarounds, including a major restructuring project for a private equity-backed company in Canada. This experience—handling financial instability, reorganizing operations, and driving expansion, shaped his leadership philosophy.

When he joined Affidea in 2017, he was drawn to healthcare’s immediate impact on daily life. “Too often, patients face long waiting times, sometimes months or even years, for essential diagnostics such as MRI scans or specialist consultations,” he says. Our role is to help address that challenge by making healthcare more accessible, timely and patient-centred. The company’s expansion aligns with this goal, covering urgent care, outpatient services, and preventive initiatives like its Heart Health Check program, which helps patients evaluate cardiovascular risks before complications develop.

Expanding with Belfast’s new healthcare hub

Financial backing has fueled Affidea’s growth strategy. Strong shareholder support enables disciplined expansion through acquisitions, new facility development, and service enhancements. The latest initiative is a 100,000-square-foot healthcare complex under construction in Belfast on Boucher Road. The facility will provide advanced diagnostic imaging, specialist consultations, outpatient procedures and inpatient surgery, enhancing access to high-quality healthcare services across the region.

Downes credits his achievements to a blend of commercial acumen, operational precision, and problem-solving skills. A piece of early career advice remains central to his decisions: “One of the best pieces of advice I ever received was to trust your gut, particularly when it comes to people decisions, whether hiring or managing performance.” This principle guides hiring, performance reviews, and crisis responses.

Digital advancements have gained momentum since the pandemic, though Downes observes that healthcare lags in adoption. While telehealth and digital diagnostics have grown, the sector now faces fragmentation. Not every solution will last, he warns. Long-term success depends on practical scalability, cross-sector collaboration, and tangible improvements in patient outcomes, not just technological novelty.

Advocating for flexible career paths and SMEs

Reflecting on his career, Downes has minimal regrets. If he could alter one aspect, it would be his early professional path. He now advocates for greater flexibility in education and early career choices, including trades and apprenticeships as valid entry points. “Young people often feel pressured to commit to a single trajectory early on,” he explains. “In truth, careers evolve over time, and diverse routes can produce equally strong results.”

Read Also: Patrick Masterson shares insights on entrepreneurship

His respect extends beyond corporate leaders. Downes frequently highlights Ireland’s small and medium-sized enterprises (SMEs) as the economic backbone. “SMEs are the backbone of the Irish economy and play a critical role in driving employment and regional development. In my view, there is a need for continued focus on ensuring they are properly supported so they can thrive and realise their full potential.” This dual focus, balancing business discipline with attention to people and systems, defines his leadership approach.

Affidea’s growth goes beyond size. It targets critical gaps in access and reduces wait times by delivering services closer to home. Downes’ background, engineering, turnaround expertise, and operational rigor, provides a distinct perspective on healthcare’s obstacles. His overarching objective remains unchanged: ensuring patients receive the care they require, when they need it, without unnecessary obstacles.

The company’s next major project is the Belfast hub, which will feature three MRI scanners and two CT scanners, along with dedicated spaces for dermatology and cardiology consultations. This facility will also include a 24-bed inpatient unit, allowing Affidea to handle more complex cases without overburdening public hospitals. Downes emphasizes that the design prioritizes patient flow efficiency, with shorter wait times for diagnostics and faster referrals to specialists.

AI and training boost efficiency and staffing

Affidea has partnered with local universities to create 120 new training positions for radiographers, nurses, and healthcare assistants, addressing staffing shortages in the sector. The company is also piloting an AI-assisted diagnostic tool for X-ray analysis, which has reduced interpretation errors by 25% in internal trials.

When asked about Affidea’s competitive edge, Downes points to three factors: clinical quality, operational efficiency, and community integration. “We don’t just build facilities, we design them around patient journeys,” he states. For example, the Belfast hub will feature a dedicated “one-stop shop” area where patients can complete multiple diagnostic tests in a single visit, cutting travel time and anxiety.

Looking ahead, Affidea is exploring partnerships with private equity firms to fund further expansion, though Downes insists on maintaining clinical independence. “Our priority is patient care, not shareholder returns,” he clarifies.